ACTRN12617000050358招募中未知
Australian and New Zealand Lymphoma and Related Diseases Registry
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 8,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Patients with a new diagnosis of non-Hodgkin lymphoma, Hodgkin lymphoma, chronic lymphocytic leukaemia and related diseases. Diagnosis within 6 months prior to HREC approval at the site, in order to minimise retrospective data collection.
- •Age 18 years or older
- •Cause of death listed as lymphoma.
排除标准
- •Patients who have chosen to ‘opt-off’ the registry.
研究者
相似试验
进行中（未招募）
2 期
A study for patients with newly diagnosed Chronic Phase Myeloid Leukaemia evaluating the drug Asciminib.ACTRN12620000851965Australiasian Leukaemia and Lymphoma Group101
招募中
不适用
Australasian Leukaemia and Lymphoma Group National Blood Cancer RegistrySuspected or Known or Diagnosed Blood CancerCancer - Leukaemia - Acute leukaemiaPublic Health - Health service researchCancer - Lymphoma (non Hodgkin's lymphoma) - Low grade lymphomaACTRN12612000337875Australasian Leukaemia and Lymphoma Group2,000
已完成
不适用
Medical Research Council Adult Acute Lymphoblastic Leukaemia Trial UKALL XAeukaemia (acute)Lymphoid leukaemiaCancerISRCTN35362654Medical Research Council (MRC) (UK)618
已完成
不适用
Medical Research Council Acute Lymphoblastic Leukaemia Trial in Children UKALL R1eukaemia (acute)CancerLeukaemiaISRCTN13327255Medical Research Council (MRC) (UK)256
招募中
2 期
HL35: A study of Pembrolizumab And Chemo-Immunotherapy as FIrst-line therapy for patients with primary mediastinal B-Cell lymphoma.Primary mediastinal B-cell lymphomaCancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphomaACTRN12621001529831Australasian Lymphoma and Leukaemia Group35